Role of chronic prostatic infiltrate from specimens of prostate biopsy in total and free PSA determination;Influencia de la inflamación crónica prostática en muestras de biopsia sextante en los niveles séricos de PSA total y PSA libre

Actas Urologicas Espanolas

Volumn 29, Issue 2, 2005, Pages 170-173

  Gomez Perez L ^a   Budia Alba A ^a   Benedicto Redon A ^a   Delgado Oliva, F J ^a   Palmero Marti J L P ^a   Jimenez Cruz J F ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Chronic inflammation; Prostate biopsy; PSA

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; BLOOD; CHRONIC DISEASE; COMPARATIVE STUDY; HUMAN; MALE; NEEDLE BIOPSY; PATHOLOGY; PROSTATE; PROSTATITIS; RETROSPECTIVE STUDY;

AGED; BIOPSY, NEEDLE; CHRONIC DISEASE; HUMANS; MALE; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATITIS; RETROSPECTIVE STUDIES;

EID: 20144378667     PISSN: 02104806     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0210-4806(05)73219-8     Document Type: Article

References (14)

1. Stamey TA, Yang N, Hay AR, Mcneal JE, Freiha FS, Redwine E. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 1987;317:909-916.
2. Hudson MA, Bahnson RR, Catalona WJ. Clinical use of prostate specific antigen in patients with prostate cancer. J Urol 1989;142:1011-1017.
3. Catalona WJ, Smith DS, Ratliff TL, Dodds KM, Coplen DE, Yuan JJ, et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 1991;324:1156-1161.
4. Polascik TJ, Oesterling JE, Partin AW. Prostate specific antigen: a decade of discovery-what we have learned and where we are going. J Urol 1999;162:293-306.
5. Bozeman CB, Carver BS, Eastham JA, Venable DD. Treatment of chronic prostatitis lowers serum prostate specific antigen. J Urol 2002;167:1723-1726.
6. Brawn PN, Speights VO, Kuhl D, Riggs M, Spiekerman AM, Mccord RG, et al. Prostate-specific antigen levels from completely sectioned, clinically benign, whole prostates. Cancer 1991;68:1592-1599.
7. Soler Soler JL, Martínez Torres JL, Hidalgo Domínguez MR, Lardelli Claret P, Liebana Urena J, Zuluaga Gómez A, et al. Inflammatory changes in the obstructed prostate: the correlation between the bacteriological and histological findings. Arch Esp Urol 1999;52:729-738.
8. Ornstein DK, Smith DS, Humphrey PA, Catalona WJ. The effect of prostate volume, age, total prostate specific antigen level and acute inflammation on the percentage of free serum prostate specific antigen levels in men without clinically detectable prostate cancer. J Urol 1998;159:1234-1237.
9. Jung K, Meyer A, Lein M, Rudolph B, Schnorr D, Loenig SA. Ratio of free-to-total prostate specific antigen in serum cannot distinguish patients with prostate cancer from those with chronic inflammation of the prostate. J Urol 1998 May;159 (5):1595-1598.
10. Kohnen PW, Drach GW. Patterns of inflammation in prostatic hyperplasia: a histologic and bacteriologic study. J Urol 1979;121:755-760.
11. Irani J, Levillain P, Goujon JM, Bon D, Dore B, Aubert J. Inflammation in benign prostatic hyperplasia: correlation with prostate specific antigen value. J Urol, 1997;157(4):1301-1303.
12. Nadler RB, Humphrey PA, Smith DS, Catalona WJ, Ratliff TL. Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels. J Urol, 1995;154(2 Pt 1):407-413.
13. Hasui Y, Marutsuka K, Asada Y, Ide H, Nishi S, Osada Y. Relationship between serum prostate specific antigen and histological prostatitis in patients with benign prostatic hyperplasia. Prostate 1994;25(2):91-96.
14. Morote J, López M, Encabo G, De Torres IM. Effect of inflammation and benign prostatic enlargement on total and percent free serum prostatic specific antigen. Eur Urol 2000;37:537-540.